COVID-19
COVID-19 Microbiota
11 JAN 2021: Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 (Gut)“Associations between gut microbiota composition, levels of cytokines and inflammatory markers in patients with COVID-19 suggest that the gut microbiome is involved in the magnitude of COVID-19 severity possibly via modulating host immune responses. Furthermore, the gut microbiota […]
COVID-19 Liver
Published August 12, 2022
Sulforaphane exhibits antiviral activity against SARS-CoV-2 in vitro and in mice
“We determined that SFN has potent antiviral activity against HCoV-OC43 and multiple strains of SARS-CoV-2, including Delta and Omicron … “we documented that SFN can inhibit in vitro and in vivo replication of SARS-CoV-2 at pharmacologically and potentially therapeutically achievable concentrations. Further, it can modulate the inflammatory response, thereby decreasing the consequences of infection in […]
COVID-19 Literature V
literature published in 2022 Updated December 11, 2022
COVID-19 Autoimmunity
Updated July 4, 2022
COVID-19 Literature IV
literature published Oct 2020 – Dec 2021 Updated December 4, 2022
SARS-CoV-2: Chronic Infection and Variants of Concern
Updated Dec 11, 2022 3 DEC 2020: Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host (NEJM)“Phylogenetic analysis was consistent with persistent infection and accelerated viral evolution. Amino acid changes were predominantly in the spike gene and the receptor-binding domain, which make up 13% and 2%” 5 FEB 2021: SARS-CoV-2 evolution during treatment of chronic […]
COVID-19 Immunity
Updated December 5, 2022
COVID-19 Obesity
Updated January 24, 2022
COVID-19 Neuro
Updated December 4, 2022